ArticleInternational journal of toxicology

Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid Tumors.

Brian T Welsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.